Abstract
Despite improvements in cardiovascular implantable electronic device (CIED) design, application of timely infection control practices, and administration of antibiotic prophylaxis at the time of device placement, CIED infections continue to occur and can be life-threatening. This has prompted the study of all aspects of CIED infections. Recognizing the recent advances in our understanding of the epidemiology, risk factors, microbiology, management, and prevention of CIED infections, the American Heart Association commissioned this scientific statement to educate clinicians about CIED infections, provide explicit recommendations for the care of patients with suspected or established CIED infections, and highlight areas of needed research.
Original language | English (US) |
---|---|
Pages (from-to) | 458-477 |
Number of pages | 20 |
Journal | Circulation |
Volume | 121 |
Issue number | 3 |
DOIs | |
State | Published - Jan 26 2010 |
Keywords
- AHA Scientific Statements
- Device, cardiovascular
- Endocarditis
- Implantable cardioverter-defibrillator
- Implantable electronic device
- Infection
- Pacemaker
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Physiology (medical)